Since plasma adiponectin levels are decreased in those with obesity, insulin resistance, or type 2 diabetes [21], adiponectin level is considered to be a biomarker of the metabolic syndrome [22]. This evidence concerns the gene ADIPOQ and metabolic syndrome.